1. In this randomized crossover trial, intravenous levothyroxine, given to hemodynamically unstable brain-dead potential heart donors, did not improve the heart transplant success rates compared to placebo. 2. Levothyroxine resulted in more severe hypertension and tachycardia as compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: The majority of transplanted hearts come from brain-dead
UNIJOS unveils N1bn equipment to facilitate organ treatment vanguardngr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vanguardngr.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The American Association of Kidney Patients (AAKP), the nation s largest independent kidney patient organization, today announced the names of.
/PRNewswire/ The American Association of Kidney Patients (AAKP), the nation s largest independent kidney patient organization, today announced the names of.
KIDNEY ADVOCATES RECEIVE U.S. PRESIDENT'S ACHIEVEMENT AWARD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Voltron Therapeutics, Inc. today announced that life science veteran, Dr. Tony Hodges, has joined the Company as Senior Scientific Advisor. Dr..
/PRNewswire/ Voltron Therapeutics, Inc. today announced that life science veteran, Dr. Tony Hodges, has joined the Company as Senior Scientific Advisor. Dr..
/PRNewswire/ Fresenius Medical Care North America (FMCNA), the nation s leading provider of kidney care products and services, today announced an increase.